Table 4 Predictors of development of de novo post-transplant type 2 diabetes (adjusted hazard ratio with 95 % confidence interval is calculated using Cox proportional hazard model). Total N used in the model = 13,000: n_c = 9999 censored, n_e = 3,001 events (de novo DM onset)

NASH

1.29 (1.18–1.41)

Calendar year

0.92 (0.91–0.94)

Age at transplant, per year

1.02 (1.01–1.02)

African-American

1.32 (1.16–1.51)

Hispanic

1.11 (0.99–1.24)

Asian

0.99 (0.84–1.17)

Male gender

1.11 (1.03–1.19)

Overweight

1.13 (1.04–1.24)

Obese

1.32 (1.21–1.45)

Liver malignancy

0.96 (0.86–1.08)

Pre-transplant CAD

1.19 (0.92–1.53)

Pre-transplant hypertension

1.05 (0.96–1.15)

Donor’s age, per year

1.002 (1.000–1.004)

Procurement from a non-heart-beating donor

1.24 (1.04–1.46)

Donor’s history of DM

1.09 (0.96–1.22)

Use of tacrolimus *)

0.98 (0.83–1.15)

Use of mycophenolates *)

0.92 (0.84–1.02)

Use of steroids *)

1.87 (1.49–2.34)